# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-24-001557
Filing Date
2024-03-25
Accepted
2024-03-25 10:46:10
Documents
9
Period of Report
2024-03-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | f6k_032124.htm | 6-K | 34215
2 | GRAPHIC | f6k_01.jpg | GRAPHIC | 242373
3 | GRAPHIC | f6k_02.jpg | GRAPHIC | 58150
4 | GRAPHIC | f6k_03.jpg | GRAPHIC | 278822
5 | GRAPHIC | f6k_04.jpg | GRAPHIC | 309569
6 | GRAPHIC | f6k_05.jpg | GRAPHIC | 288873
7 | GRAPHIC | f6k_06.jpg | GRAPHIC | 308640
8 | GRAPHIC | f6k_07.jpg | GRAPHIC | 268216
9 | GRAPHIC | f6k_08.jpg | GRAPHIC | 118127
| Complete submission text file | 0001171843-24-001557.txt |  | 2607262

Mailing Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000
Business Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000 4544448888
NOVO NORDISK A S (Filer) CIK: 0000353278 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 333-82318 | Film No.: 24777390
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)